tiprankstipranks
Is YMAB a Buy, Before Earnings?
PremiumPre-EarningsIs YMAB a Buy, Before Earnings?
17d ago
Y-mAbs Partners with Nobelpharma for Japan Expansion
Premium
Company Announcements
Y-mAbs Partners with Nobelpharma for Japan Expansion
19d ago
Y-mAbs, Nobelpharma announce exclusive license, distribution agreement
Premium
The Fly
Y-mAbs, Nobelpharma announce exclusive license, distribution agreement
19d ago
Y-mAbs Therapeutics price target lowered to $11 from $12 at Morgan Stanley
PremiumThe FlyY-mAbs Therapeutics price target lowered to $11 from $12 at Morgan Stanley
3M ago
Y-mAbs Therapeutics price target lowered to $25 from $26 at BMO Capital
Premium
The Fly
Y-mAbs Therapeutics price target lowered to $25 from $26 at BMO Capital
3M ago
Morning Movers: KeyCorp surges following Scotiabank taking stake
Premium
The Fly
Morning Movers: KeyCorp surges following Scotiabank taking stake
3M ago
Y-mAbs Therapeutics Finalizes CFO Transition and Advisory Deal
PremiumCompany AnnouncementsY-mAbs Therapeutics Finalizes CFO Transition and Advisory Deal
4M ago
Y-mAbs Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Y-mAbs Therapeutics initiated with a Buy at JonesResearch
4M ago
Y-Mabs Therapeutics Welcomes New CFO Amid Strategic Shift
Premium
Company Announcements
Y-Mabs Therapeutics Welcomes New CFO Amid Strategic Shift
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100